Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
IPO
Analysis: Why Digital Health Investors are Falling in Love with Femtech
Women’s health technology, known as Femtech, is one of the fastest-growing and well-funded categories of digital health. Femtech generally encompasses a range of digital health software and tech-enabled service providers that cater to the specific biological needs of women. These needs span from general health and wellness to reproductive health, including fertility, pregnancy, and nursing care.
Today, reproductive health is the focal point of femtech, thanks in part to the
Read More
Analysis: January Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of January 2020.
Ten years into the bull market, we operate in a heightened state of awareness for any indication of market weakness that may signal a downturn. While debt levels are rising and GDP growth somewhat sluggish, the world of private equity, public equity, and M&A continues to be in full swing bull market
Read More
2020 Semi-Annual Health IT Market Review: 5 Key Indicators to Watch
- Healthcare Growth Partners (HGP) releases its Semi-Annual Health IT Market Review report that summarizes M&A and private equity activity across health IT, digital health, etc.
- The report reveals health IT as a healthy sector going into 2020 and outlines key 2019 trends and 2020 indicators to watch in the market this year.
Healthcare Growth Partners, an investment bank and strategic advisory firm for health IT has announced the release of its annual Semi-Annual Health IT Market
Read More
Top Global Digital Health/Health IT VC Funding Categories in Q3 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reached $2B in funding across 156 deals in Q3 2019, according to market research firm Mercom Capital Group. The 9M & Q3 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals global venture capital reached $7.2B over 474 deals in the first nine months of 2019 compared to $8B in 556 deals in 9M 2018. In Q3 2019, Digital Health companies raised $2B in 156
Read More
Q3 2019 Digital Health Funding Levels Off At $1.3B, Rock Health Reports
- New Rock Health report finds digital health funding reaches $1.3B in Q3 2019 for a total of $5.5B year to date. - Large digital health funding round are driving the overall funding trend in digital health with the average deal size at $20.9M, in line with 2018’s $21.7M average deal size. - Rock Health projects the number of digital health deals in 2019 will be 5-10% lower than in 2018.Digital health funding reached a total of $1.3B in Q3 2019 for a total of $5.5B year to date, leveling off
Read More
The Drought is Over: It’s Raining Health IT IPOs
Three venture-backed health IT companies completed IPOs in July, ending an almost three-year drought of health IT IPOs. Share prices soared following each IPO, indicative of the enthusiastic response and a desire to see more health IT companies make their way toward public debuts. Composition of revenue, gross margin, and growth are key differentiators between these and all companies and key drivers of valuation. Given the enthusiastic shareholder response to these listings, we
Read More
Research: July Digital Health IPOs, M&A Activity, Public Company Performance Summary
Summary of Health IT/digital IPOs, merger & acquisition (M&A) activity, and public company performance during the month of July.
Digital Health IPOs in July
Breaking the digital health IPO drought, there were four initial public offerings (IPOs) during a five-week period from late June to late July, including Livongo, Health Catalyst, Phreesia, and Change Healthcare. The last health IT companies to reach IPO were iRhythym Technologies and Tabula Rasa Healthcare in late 2016 -
Read More
Health Catalyst IPO Journey: Future Opportunities & Challenges to Watch
Last week saw Health Catalyst common stock begin trading on the Nasdaq Global Select Market. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximized the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive future success. Here’s our
Read More
Global Digital Health VC Funding Breaks $5.1B in First Half of 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $5.1 billion in the first half of 2019, according to market research firm Mercom Capital. The 1H and Q2 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $5.1B in funding across 318 deals compared to $4.9B across 383 deals in 1H 2018. Q2 2019 VC funding held strong at $3.1 billion in 169 deals following the $2 billion raised in 149 deals in Q1 2019.
Read More
